Vivos Therapeutics, Inc. Public Float
Vivos Therapeutics, Inc. (VVOS) had Public Float of $22.90 million as of 2025-06-30, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-15
- 2025-06-30: Entity Public Float $22.90M.
- 2024-06-28: Entity Public Float $7.40M.
- 2023-06-30: Entity Public Float $15.30M.
- 2022-06-30: Entity Public Float $23.20M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $22.90M 10-K · filed 2026-04-15 |
| 2024-06-28 | $7.40M 10-K · filed 2025-03-31 |
| 2023-06-30 | $15.30M 10-K/A · filed 2024-07-30 |
| 2022-06-30 | $23.20M 10-K · filed 2023-03-30 |
| 2021-06-30 | $88.30M 10-K · filed 2022-03-31 |
| 2020-12-31 | $73.00M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |